Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer Meeting Abstract
| Authors: | Rizvi, N. A.; Rusch, V.; Zhao, B.; Senturk, E.; Schwartz, L.; Fury, M.; Downey, R.; Rizk, N.; Krug, L.; Kris, M. G. |
| Abstract Title: | Single agent bevacizumab and bevacizumab in combination with docetaxel and cisplatin as induction therapy for resectable IB-IIIA non-small cell lung cancer |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 687s |
| Language: | English |
| ACCESSION: | WOS:000455043704443 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.18045 |
| Notes: | Meeting Abstract: 18045 -- Source: Wos |
